What is the evidence for the safety and effectiveness of surgical and non-surgical interventions for patients with morbid obesity?
The review updates the New Zealand Ministry of Health on the evidence for the safety, clinical and cost-effectiveness of surgical and non-surgical interventions for patients with morbid obesity defined as persons with a BMI = 40 kg/m2 or BMI = 35 kg/m2 with significant obesity related co-morbidities. Systematic and non-systematic literature reviews have been undertaken internationally by Health Technology Assessment Agencies (HTA) evaluating surgical and non-surgical interventions for patients with morbid obesity. The purpose of this Technical Brief was to provide a descriptive overview of the HTA review material published between 2000 and 2004 and also to incorporate recent evidence from studies published in peer reviewed journals for 2003 and 2004 not already included in the HTA reviews.
- Biliopancreatic Diversion
- Costs and Cost Analysis
- Gastric Bypass
- Gastroplasty
- Obesity
- Obesity, Morbid